ZAPPULO, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 997
EU - Europa 607
AS - Asia 297
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.927
Nazione #
US - Stati Uniti d'America 963
IT - Italia 248
SG - Singapore 207
NL - Olanda 113
DE - Germania 111
CN - Cina 67
UA - Ucraina 33
CA - Canada 32
IE - Irlanda 26
FI - Finlandia 24
CI - Costa d'Avorio 19
CH - Svizzera 18
GB - Regno Unito 13
FR - Francia 11
IN - India 9
VN - Vietnam 7
EG - Egitto 4
AT - Austria 2
HK - Hong Kong 2
MK - Macedonia 2
MX - Messico 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BE - Belgio 1
CL - Cile 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
KZ - Kazakistan 1
LT - Lituania 1
PK - Pakistan 1
PL - Polonia 1
SI - Slovenia 1
Totale 1.927
Città #
Chandler 179
Singapore 170
Amsterdam 109
Ashburn 106
Naples 71
Millbury 57
Santa Clara 45
Des Moines 37
Krefeld 32
Napoli 31
Ottawa 28
Lawrence 25
Princeton 23
Boston 19
Nanjing 18
Basel 17
Boardman 17
Wilmington 14
Beijing 11
Seattle 10
Washington 7
Hebei 6
Nanchang 6
Pune 6
Tianjin 6
Milan 5
Bologna 4
Council Bluffs 4
Dong Ket 4
Los Angeles 4
Pomigliano D'arco 4
Qualiano 4
Brescia 3
Chicago 3
Dallas 3
Dung 3
Helsinki 3
Kronberg 3
Montalbano Jonico 3
Rome 3
Shenyang 3
Acquaviva Delle Fonti 2
Cairo 2
Changsha 2
Dublin 2
Fairfield 2
Formia 2
Gualtieri 2
Hanover 2
Hong Kong 2
Hyderabad 2
Jinan 2
Lanzhou 2
Lappeenranta 2
Marseille 2
New York 2
Norwalk 2
Nuremberg 2
Palermo 2
Paris 2
Pozzuoli 2
Redwood City 2
Richland 2
Richmond 2
Serra 2
Skopje 2
Sorrento 2
Vittorio Veneto 2
Abidjan 1
Agropoli 1
Alcamo 1
Andover 1
Astana 1
Aversa 1
Bari 1
Bayreuth 1
Brussels 1
Caivano 1
Casalnuovo Di Napoli 1
Caserta 1
Casoria 1
Castellammare di Stabia 1
Catania 1
Cava De' Tirreni 1
Città Di Castello 1
Cologno Monzese 1
Columbus 1
Crispano 1
Dubai 1
Duncan 1
Edinburgh 1
Ercolano 1
Foggia 1
Fremont 1
Galveston 1
Houston 1
Indiana 1
Jiaxing 1
La Canada Flintridge 1
Ljubljana 1
Totale 1.192
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 132
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 64
Infezione da cytomegalovirus 60
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 59
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 52
Asunaprevir for hepatitis C: A safety evaluation 52
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 50
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 44
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 41
Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia 41
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 40
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 40
Beclabuvir for the treatment of hepatitis C 40
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 40
Il Virus varicella Zoster 40
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak 40
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 38
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 37
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 36
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 35
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 35
DNA detection of herpetic viruses in dried blood spots in children with autism spectrum disorders 34
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 34
Epstein-Barr virus 33
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 33
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 33
Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report 32
Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders 32
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 32
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 30
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience 30
Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder. 29
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 29
Response to measles-mumps-rubella vaccine in children with autistic spectrum disorders 28
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 27
Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. 27
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 27
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 26
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 26
HSV 25
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 25
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 25
Prevalence of human herpesvirus-6 and epstein barr virus infections in children with autistic spectrum disorders 24
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 24
Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens 24
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg 23
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 22
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 22
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 22
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 21
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 21
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 21
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? 20
Diabetes and COVID-19: The potential role of mTOR 19
No evidence of congenital varicella zoster virus infection assessed through dried blood spot in children with autism spectrum disorders 19
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 17
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 17
Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development 17
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 17
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience 16
Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection 16
Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis 14
The role of curcumin in liver diseases 12
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 8
Trabecular bone score assessed by dual-energy X ray absorption predicts vertebral fractures in HIV infected young adults 5
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy 5
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 4
Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis 4
Totale 2.067
Categoria #
all - tutte 10.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.601


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202056 0 0 0 0 10 3 3 2 2 4 21 11
2020/2021115 20 4 6 9 17 7 8 3 16 17 1 7
2021/2022290 5 3 3 2 1 12 1 10 27 30 77 119
2022/2023644 51 31 20 35 55 61 22 157 66 116 25 5
2023/2024425 15 68 76 33 24 74 3 35 7 7 44 39
2024/2025274 87 74 11 44 58 0 0 0 0 0 0 0
Totale 2.067